局部抗生素递送降低无引流组织扩张器乳房再造感染
单术者回顾性队列研究纳入52例患者93侧乳房,比较可吸收抗生素珠与不可吸收抗生素板在无引流胸肌前组织扩张器乳房再造中的感染预防效果。珠组临床感染率18.8%显著高于板组2.2%(P=0.016),两组血清肿、疼痛评分及额外镇痛需求无差异。不可吸收抗生素板与更低感染率相关且不损害术后舒适度。
要点
- 不可吸收抗生素板组临床感染率2.2%,显著低于可吸收珠组18.8%(P=0.016)。
- 珠组感染平均发生于术后93天,万古霉素/妥布霉素亚组感染率30%。
- 两组血清肿、疼痛评分及出院后额外镇痛需求无差异。
核心结论
- 不可吸收抗生素板与降低感染率相关,且不损害术后舒适度、引流或出院后镇痛需求。
- 抗生素板是组织扩张器乳房再造中安全有效的感染预防策略。
研究设计与样本
- 单术者回顾性队列研究,纳入2024年4月至2025年8月接受乳房切除及即刻胸肌前无引流组织扩张器再造的患者。
- 共93侧乳房来自52例患者,可吸收抗生素珠组48侧,不可吸收抗生素板组45侧。
- 主要结局为组织扩张器术后临床乳房感染。
主要发现
- 珠组临床感染率18.8%(9/48),板组2.2%(1/45),P=0.016。
- 珠组感染平均发生于术后93天。
- 珠组亚组分析:万古霉素/庆大霉素组合感染3例,万古霉素/妥布霉素组合感染6例(10.7% vs 30%,P=0.137)。
- 两组血清肿率、术后疼痛评分及出院后额外镇痛需求无差异。
临床怎么用
- 在无引流胸肌前组织扩张器乳房再造中,可优先考虑不可吸收抗生素板而非可吸收抗生素珠以降低感染风险。
- 术后需关注迟发感染,珠组感染平均发生于术后93天。
局限性
- 单术者回顾性队列研究,样本量有限(52例患者93侧乳房)。
- 可吸收珠组两种抗生素组合使用时段不同,可能存在时间偏倚。
- 亚组比较样本量小,感染率差异未达统计学显著性(P=0.137)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast infection during tissue expander (TE)-based breast reconstruction remains a significant clinical challenge. This study evaluates the effectiveness of absorbable antibiotic beads compared to nonabsorbable antibiotic plates in preventing infection in TE-based breast reconstruction. METHODS: This was a single-surgeon retrospective cohort study of patients undergoing mastectomy and immediate prepectoral, drainless TE reconstruction between April 2024 and August 2025. At the time of TE reconstruction, patients either underwent placement of absorbable antibiotic beads (vancomycin/gentamicin: April 2024-August 2024; vancomycin/tobramycin: July 2024-October 2024) or nonabsorbable antibiotic plates (November 2024-August 2025: vancomycin/tobramycin). The primary outcome was clinical breast infection during the TE postoperative period. RESULTS: Ninety-three breasts from 52 patients were included (48 breasts with beads, 45 breasts with plates). The bead cohort had a significantly higher rate of clinical infection compared to the plate cohort (18.8% vs 2.2%, P = 0.016 ), with infection occurring at a mean of 93 days postoperatively. Subgroup analysis revealed that among the breast infections with beads, 3 occurred with the vancomycin and gentamicin combination and 6 occurred with the vancomycin and tobramycin combination (10.7% vs 30%, P = 0.137). There were no differences between cohorts in seroma rates, postoperative pain scores, or additional analgesic requirements after discharge. CONCLUSIONS: Nonabsorbable antibiotic plates were associated with reduced infection rates without compromising postoperative comfort, drainage, or analgesic needs after discharge. These findings suggest that antibiotic plates are a safe and effective strategy for infection prevention in TE-based breast reconstruction.
引用
- Vaeth AM, McVeigh A, Huang H, et al. Reducing Infection in Drainless Tissue Expander-Based Breast Reconstruction With Local Antibiotic Delivery. Ann Plast Surg. 2026. PMID: 41616258. doi:10.1097/SAP.0000000000004642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。